Page 6 - Beta Bionics News Today

Beta Bionics appointed Dr. Steven Russell as its chief medical officer (CMO) as it readies itself for a major product launch.

Caution: The iLet Bionic Pancreas is an investigational device limited by Federal law to investigational use. Not available for sale....

A roundup of some of 2022’s best facts and findings from The Brink, Boston University’s research news site.

The threshold suspended device systems segment held the major market share among the type segment in the artificial pancreas device systems market

Increasing incidence of diabetes is expected to enhance the growth of artificial pancreas device systems market from 2018 to 2025.

New York, NY (PRWEB) November 16, 2022 -- The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of San Diego for

New York, NY (PRWEB) November 09, 2022 -- The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Los Angeles for

A clinical trial finds a bionic pancreas device that autonomously delivers insulin in the right dose improves type 1 diabetes management.

Study in the New England Journal of Medicine finds iLet bionic pancreas is better at managing blood glucose levels than existing care options.

Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.